Characterization of the specificity of peptide binding to four DR haplotypes.
Donal M. O’Sullivan(Cytel (United States)), Alessandro Sette(La Jolla Institute for Immunology), Ettore Appella(National Institutes of Health), John Sidney(La Jolla Institute for Immunology), Lorelle D. Phillips(Cytel (United States)), Robert W. Chesnut(Cytel (United States)), S M Colón(Cytel (United States)), L E Walker(University of Southern California), C Miles(Prime Solutions Group (United States))
Cited by 132
Related Papers
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
|Cell|2020|4k
DNA damage activates p53 through a phosphorylation–acetylation cascade
|Genes & Development|1998|1.2k
HLA class I supertypes: a revised and updated classification
|BMC Immunology|2008|801